Fast and Sensitive Multiplex Real-Time Quantitative PCR to Detect Cutibacterium Periprosthetic Joint Infections

Julia Prinz1, Bettina Schmid2, Reinhard Zbinden3

  • 1Department of Dermatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.

Insights

A new multiplex qPCR test offers rapid diagnosis of Cutibacterium periprosthetic joint infections (PJIs) within one day. This faster method aids early and accurate antibiotic treatment for patients with these challenging infections.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Molecular Diagnostics

Background:

  • Periprosthetic joint infections (PJIs) caused by Cutibacterium species present diagnostic challenges due to lengthy culture times (up to 14 days).
  • Delayed diagnosis of Cutibacterium PJIs can impede timely and effective patient treatment.
  • Culture-independent methods are needed for faster and more accurate PJI diagnostics.

Purpose of the Study:

  • To develop and evaluate a multiplex real-time quantitative PCR (qPCR) assay for the rapid detection of Cutibacterium species in PJI samples.
  • To assess the diagnostic performance of the multiplex qPCR compared to traditional culture methods.

Main Methods:

  • Design of specific primers and probes for Cutibacterium acnes, C. avidum, and C. granulosum.
  • Development of a multiplex TaqMan real-time quantitative PCR (qPCR) assay.
  • Validation using skin swabs, cerebrospinal fluid samples, and sonication fluid from PJI patients.

Main Results:

  • The multiplex qPCR achieved 100% positive percent agreement for culture-positive Cutibacterium PJIs.
  • It detected C. avidum in two PJI samples misidentified by culture as Staphylococcus species (95% negative percent agreement).
  • The assay provides diagnostic results within one day, significantly faster than conventional cultures.

Conclusions:

  • The developed multiplex qPCR assay enables rapid and accurate diagnosis of Cutibacterium PJIs.
  • This molecular approach facilitates early initiation of appropriate antibiotic therapy.
  • Further prospective trials, particularly in high Cutibacterium prevalence settings like shoulder PJIs, are warranted for full evaluation.